Lactobacillus reuteri

Strain UALre-16 (UAS Labs)

A friendly bacterium of the human gut, also found in breast milk, and one half of the most-studied probiotic pair in women's health.

544women in a vaginal flora trial of a related strain
Breast milkone of the places it's naturally found
10strains in the Daily Probiotic blend

Why we love it

L. reuteri is one of the species that naturally live in the human gut. It is also part of the best-known oral probiotic pairing studied in women, so we wanted it alongside L. rhamnosus in our blend.

What does the research show?

Bacterial vaginosis (BV)

Researchers gave oral RC-14 with GR-1 alongside antibiotics. In a trial of 125 women, 88% were cured at 30 days compared with 40% on antibiotics plus placebo. A trial of 544 women found healthy flora returned in 62% vs 27% on placebo. A later trial of 126 women in China found no added benefit.

Vaginal yeast

In 55 women given one dose of fluconazole, those who also took RC-14 with GR-1 for 4 weeks had less yeast on culture (10% vs 39%).

Urinary tract

In 252 postmenopausal women with repeat UTIs, the pair was less effective than a daily antibiotic over a year, but did not raise antibiotic resistance.

Pregnancy

In 110 pregnant women carrying group B strep, 43% tested negative after taking the pair, compared with 18% on placebo.

Babies and children

The strain DSM 17938 was studied in 345 babies with colic. Breastfed babies cried about 25 minutes less per day by day 21. In 336 children in day care, it was linked with fewer diarrhea episodes and fewer days of respiratory infection.

Bone

In 90 women aged 75 to 80, the strain ATCC PTA 6475 was linked with less bone loss in the shin over a year (0.8% vs 1.9% on placebo).

Studies

Human study tested in people   Lab study a starting point, not proof

Studies on other strains of this species

Human study Randomized, placebo-controlled, 125 women with BV, with antibiotics

Strain: RC-14 with GR-1, oral

Cured at 30 days: 88% vs 40%

Anukam 2006, Microbes and Infection · Source

Human study Randomized, placebo-controlled, 544 women with BV or unbalanced flora

Strain: RC-14 with GR-1, oral

Healthy flora at about 6 weeks: 62% vs 27%

Vujic 2013 · Source

Human study Randomized, placebo-controlled, 55 women with vaginal yeast, after fluconazole

Strain: RC-14 with GR-1

Yeast on culture at 4 weeks: 10% vs 39%

Martinez 2009, Letters in Applied Microbiology · Source

Human study Randomized, placebo-controlled, 110 pregnant women with group B strep

Strain: RC-14 with GR-1, oral

43% tested negative vs 18%

Ho 2016, Taiwanese Journal of Obstetrics and Gynecology · Source

Human study Combined analysis of 4 trials, 345 babies with colic

Strain: DSM 17938, oral drops

About 25 fewer minutes of crying per day at day 21 in breastfed babies; no clear effect in formula-fed babies

Sung 2018, Pediatrics · Source

Human study Randomized, placebo-controlled, 336 children in day care

Strain: DSM 17938, oral

99 vs 152 diarrhea episodes; fewer days of respiratory infection

Gutierrez-Castrellon 2014, Pediatrics · Source

Human study Randomized, placebo-controlled, 90 women aged 75 to 80

Strain: ATCC PTA 6475, oral

Shin bone density fell 0.8% vs 1.9% over 12 months

Nilsson 2018, Journal of Internal Medicine · Source

Human study Randomized trial, 126 women with BV

Strain: RC-14 with L. rhamnosus GR-1, oral

No added benefit over antibiotics alone

Zhang 2021, Frontiers in Cellular and Infection Microbiology · Source

Human study Randomized, double-blind, 252 postmenopausal women with repeat UTIs

Strain: RC-14 with GR-1, oral

Less effective than a daily antibiotic; no rise in antibiotic resistance

Beerepoot 2012, Archives of Internal Medicine · Source

Which strain do we use?

Our strain is L. reuteri UALre-16 (UAS Labs). It was also one of 10 strains in a small oral blend study (Martoni 2022), where vaginal pH fell slightly over 28 days. The other studies on this page used other strains of this species, and results belong to the strain tested.

Is L. reuteri safe to take?

The trials above reported no serious side effects, and side effects in the bone study were no different from placebo. Ask a clinician first if you have a weakened immune system, a central line or catheter, a serious illness, or are pregnant or breastfeeding.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Last reviewed: November 2026.

Found in

Related ingredients

Reviewed by the Momotaro Apotheca medical team, including OB-GYNs and naturopathic doctors. Educational information, not medical advice. All ingredient research